Business Description
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Business History
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -13.37
Total Equity: $47.72M
Shares: 17,429,861
Total Debt: $107,951
Cash: $10.79M
EBITDA: -$232.17M
Total Debt: $107,951
Cash: $10.79M
Revenue: $125,284
Shares: 17,429,861
Revenue: $125,284
Revenue: $125,284
Revenue: $125,284
Total Equity: $47.72M
Tax Rate: 0.0%
Equity: $47.72M
Total Debt: $107,951
Cash: $10.79M
Current Liabilities: $4.27M
Long-Term Debt: $0.00
Total Debt: $107,951
Total Equity: $47.72M
Shares: 17,429,861
Shares: 17,429,861
CapEx: -$32.62M
Shares: 17,429,861
Stock Price: $7.16
Net Income: -$233.10M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 23, 2026 12:44pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.4M | $1.5M | $1.6M | $1.6M | $125,284 |
| Cost of Revenue | $487,024 | $505,107 | $609,212 | $826,137 | $72,622 |
| Gross Profit | $933,656 | $1.0M | $1.0M | $797,680 | $52,662 |
| Operating Expenses | $21.4M | $27.0M | $13.1M | $11.7M | $28.5M |
| Operating Income | -$20.4M | -$26.0M | -$12.1M | -$10.9M | -$28.4M |
| Net Income | -$19.7M | -$25.7M | -$14.0M | -$12.2M | -$233.1M |
| EBITDA | -$12.1M | -$14.0M | -$11.8M | -$10.2M | -$232.2M |
| EPS | $-7.16 | $-6.98 | $-3.48 | $-2.24 | $-13.37 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 12:44pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28.2M | $22.1M | $8.7M | $734,673 | $10.8M |
| Total Current Assets | $29.5M | $23.4M | $10.1M | $2.2M | $42.8M |
| Total Assets | $43.8M | $25.7M | $14.4M | $5.0M | $52.9M |
| Current Liabilities | $3.2M | $3.9M | $4.0M | $3.6M | $4.3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.5M | $4.0M | $6.1M | $5.2M | $5.2M |
| Total Equity | $40.3M | $21.8M | $8.3M | $-202,610 | $47.7M |
| Retained Earnings | -$128.0M | -$153.8M | -$167.8M | -$180.4M | -$413.5M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 12:44pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$12.2M | -$12.4M | -$13.2M | -$12.0M | -$10.0M |
| Capital Expenditure | $-962,322 | $-475,697 | $-21,529 | $-9,509 | -$32.6M |
| Free Cash Flow | -$13.2M | -$12.8M | -$13.2M | -$12.0M | -$42.5M |
| Acquisitions (net) | -$9.6M | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $-11,526 | $-27,654 | $-1,510 | $0 | $0 |
| Net Change in Cash | $27.5M | -$6.1M | -$13.3M | -$8.0M | $10.1M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 3:57am (6h ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$9.3M $9.3M – $9.3M
|
$15.4M $15.4M – $15.4M
|
$24.0M $24.0M – $24.0M
|
$32.5M $32.5M – $32.5M
|
| EBITDA |
-$9.3M -$9.3M – -$9.3M
|
-$15.4M -$15.4M – -$15.4M
|
-$24.0M -$24.0M – -$24.0M
|
-$32.5M -$32.5M – -$32.5M
|
| Net Income |
-$34.0M -$34.0M – -$34.0M
|
$20.9M $20.9M – $20.9M
|
$70.6M $70.6M – $70.6M
|
$120.3M $120.3M – $120.3M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 12:44pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +6.0% | +8.1% | -0.2% | -92.3% |
| Gross Profit Growth | +7.1% | +1.8% | -21.7% | -93.4% |
| Operating Income Growth | -27.4% | +53.5% | +9.7% | -159.8% |
| Net Income Growth | -30.9% | +45.7% | +12.7% | -1,810.4% |
| EBITDA Growth | -15.0% | +15.6% | +13.7% | -2,184.1% |
Narrative Economics
market-narrative step).